Art. 96 Regulation (EU) 2017/745

Procedure for evaluating national measures at Union level

In forcesince 5 Apr 2017cited 7×
1.

Where, within two months of receipt of the notification referred to in Article 95(4), objections are raised by a Member State against a measure taken by another Member State, or where the Commission considers the measure to be contrary to Union law, the Commission shall, after consulting the competent authorities concerned and, where necessary, the economic operators concerned, evaluate that national measure. On the basis of the results of that evaluation, the Commission may decide, by means of implementing acts, whether or not the national measure is justified. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 114(3).

2.

Where the Commission considers the national measure to be justified as referred to in paragraph 1 of this Article, the second subparagraph of Article 95(7) shall apply. If the Commission considers the national measure to be unjustified, the Member State concerned shall withdraw the measure.

Where the Commission does not adopt a decision pursuant to paragraph 1 of this Article within eight months of receipt of the notification referred to in Article 95(4), the national measure shall be considered to be justified.

3.

Where a Member State or the Commission considers that the risk to health and safety emanating from a device cannot be mitigated satisfactorily by means of measures taken by the Member State or Member States concerned, the Commission, at the request of a Member State or on its own initiative, may take, by means of implementing acts, the necessary and duly justified measures to ensure the protection of health and safety, including measures restricting or prohibiting the placing on the market and putting into service of the device concerned. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 114(3).

  • Arrêt du Tribunal (huitième chambre) du 12 février 2025. Christoph Klein contre Commission européenne.Decision

    Le 28 avril 2023, la Commission a adopté, sur le fondement de l’article 96, paragraphe 1, du règlement (UE) 2017/745 du Parlement européen et du Conseil, du 5 avril 2017, relatif aux dispositifs médicaux, modifiant la directive …

    12 Feb 2025 · 62023TJ0394

  • Ordonnance du Tribunal (huitième chambre) du 25 avril 2023. Christoph Klein contre Commission européenne.Decision

    La Commission fait valoir également que les articles 94 à 97 du règlement 2017/745 constitueraient, à ce stade, la base juridique pertinente pour une décision de la Commission sur la mesure notifiée par la République fédérale …

    25 Apr 2023 · 62019TO0562(01)

  • MPDG76Law

    … nach Artikel 95 Absatz 7 der Verordnung (EU) 2017/745 oder Artikel 90 Absatz 7 der Verordnung (EU) 2017/746 oder nach Artikel 96 Absatz 2 der Verordnung (EU) 2017/745 oder Artikel 91 Absatz 2 der Verordnung (EU) 2017/746 als …

  • Arrêt du Tribunal (septième chambre) du 2 septembre 2026. Christoph Klein contre Commission européenne.Decision

    Am 28. April 2023 erließ die Kommission auf der Grundlage von Art. 96 Abs. 1 der Verordnung (EU) 2017/745 des Europäischen Parlaments und des Rates vom 5. April 2017 über Medizinprodukte, zur Änderung der Richtlinie 2001/83/EG, der …

    2 Sep 2026 · 62025TJ0430

  • Ordonnance du président du Tribunal du 4 août 2026. Christoph Klein contre Commission européenne.Decision

    Am 28. April 2023 erließ die Kommission auf der Grundlage von Art. 96 Abs. 1 der Verordnung (EU) 2017/745 des Europäischen Parlaments und des Rates vom 5. April 2017 über Medizinprodukte, zur Änderung der Richtlinie 2001/83/EG, der …

    4 Aug 2026 · 62026TO0267

  • Urteil des Gerichts (Achte Kammer) vom 12. Februar 2025. Christoph Klein gegen Europäische Kommission.Decision

    12 Feb 2025 · 62023TJ0394

  • MPDG76Law